Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis.
J Viral Hepat
; 27(4): 371-375, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-31756019
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carbamates
/
Hepatitis C
/
Sofosbuvir
/
Heterocyclic Compounds, 4 or More Rings
/
Liver Cirrhosis
Type of study:
Guideline
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Viral Hepat
Journal subject:
GASTROENTEROLOGIA
Year:
2020
Type:
Article
Affiliation country:
United kingdom